Kamada Ltd. Stock TEL AVIV STOCK EXCHANGE
Stocks
KMDA
IL0010941198
Pharmaceuticals
| Market Cap | 1.23B 412M 362M 333M 312M 585M 38.87B 595M 4B 1.55B 19.16B 1.55B 1.51B 66.59B | P/E 2026 * |
-
| P/E 2027 * | - |
|---|---|---|---|---|---|
| Enterprise Value | 1.23B 412M 362M 333M 312M 585M 38.87B 595M 4B 1.55B 19.16B 1.55B 1.51B 66.59B | EV / Sales 2026 * |
2.1x | EV / Sales 2027 * | 1.91x |
| Free-Float |
54.51% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Kamada Ltd.
| 1 day | +3.07% |
| Manager | Title | Age | Since |
|---|---|---|---|
Amir London
CEO | Chief Executive Officer | 57 | 2015-06-30 |
Chaime Orlev
DFI | Director of Finance/CFO | 55 | 2017-12-30 |
Eran Nir
COO | Chief Operating Officer | 53 | 2016-10-31 |
| Director | Title | Age | Since |
|---|---|---|---|
David Tsur
BRD | Director/Board Member | 75 | 1990-12-12 |
Leon Recanati
CHM | Chairman | 77 | 2013-03-06 |
| Chairman | 55 | 2020-08-11 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +3.07% | +4.32% | - | - | 412M | ||
| -0.53% | +1.67% | +19.19% | -20.47% | 63.09B | ||
| -0.19% | +2.52% | +51.66% | +216.28% | 55.61B | ||
| +0.07% | +38.60% | +38.60% | +38.60% | 41.64B | ||
| -2.36% | -1.25% | -52.13% | -58.98% | 38.98B | ||
| +1.19% | +2.74% | +58.64% | -29.02% | 29.82B | ||
| -1.11% | -6.58% | +122.45% | -49.58% | 23.71B | ||
| -0.86% | +9.48% | +59.19% | +72.19% | 21.48B | ||
| -1.25% | -0.27% | -4.39% | +142.42% | 16.87B | ||
| -1.94% | +3.73% | +65.97% | +121.83% | 16.74B | ||
| Average | -0.40% | +2.98% | +39.91% | +48.14% | 34.22B | |
| Weighted average by Cap. | -0.64% | +2.91% | +34.46% | +45.45% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 585M 196M 172M 159M 148M 278M 18.5B 283M 1.9B 737M 9.12B 736M 720M 31.69B | 642M 215M 189M 174M 163M 305M 20.31B 311M 2.09B 809M 10.01B 808M 790M 34.79B |
| Net income | 72.01M 24.14M 21.21M 19.54M 18.27M 34.27M 2.28B 34.9M 234M 90.81M 1.12B 90.67M 88.68M 3.9B | 104M 34.75M 30.52M 28.12M 26.3M 49.32M 3.28B 50.22M 337M 131M 1.62B 130M 128M 5.62B |
| Net Debt | - | - |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.

















